Over The Counter 18 Mar 2024: How AI Is Revolutionizing Personalized Wellness, With Bioniq’s Marni Allen

In this episode, HBW Insight dives into personalized wellness with Marni Allen, chief marketing officer at tailored supplements manufacturer Bioniq. Named as one of EY UK's 50 Women to Watch in 2022, Allen has over 20 years’ experience in consumer healthcare, and is now working with Bioniq to create the next generation of bespoke wellness products for consumers across the world. As well as its top tier at-home blood test-based service, Bioniq also offers an affordable questionnaire-based option, which leverages the power of AI to analyse users’ nutritional needs and provide unique supplement formulations in the post. Although personalized wellness is still somewhat niche, Allen suggests that AI-based models like Bioniq offer an attractive option for traditional consumer health companies looking to get into this fast-growing market.

HBW Over The Counter Podcast

Open Media

Further Reading

Wellness In 2024: Expect Growth Fueled By Digital And AI-Powered Personalization

‘Faster, Better, More Efficient’ – Why Bayer Is Investing In ‘Precision Health’

Bayer To Launch Healthy Aging App As Part Of Personalization Push

J&J Sees ‘Enormous’ Potential In Personalized And Digitally-Supported Self-Care

‘We’re Not In The Market For Gimmicks’ – RB's Head Of Disruptive Innovation On Personalization And Digital Health

Post-COVID Consumers Want Digitally Enabled, Personalized And Continuous Self-Care

Nurish By Nature Made Extends Pharmavite Into Personalized, Subscription VMS Market

Direct-To-Consumer Tests Opening The Door To Personalized Medicine

Further Listening

Over The Counter 22 Jan 2024: The Promise Of AI For Consumer Health, Pt 1, With The Exponential Club’s Nick Tate

Over The Counter 5 Feb 2024: The Promise Of AI For Consumer Health, Pt 2, With The Exponential Club’s Nick Tate

Over The Counter 13 Nov 2023: How OTC Companies Can Respond To Preventative Health Trends, With Simon-Kucher & Partners

Over The Counter 11 Sept 2023: Trends Shaping The OTC Industry Today, With BSS Consulting’s Birgit Schuhbauer

Over The Counter 20 March 2023: The Shape Of The Global OTC Market To Come, With IQVIA Consumer Health's Amit Shukla

Citeline podcasts are available on Apple PodcastsGoogle PodcastsSoundCloud and TuneIn - and also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider. 

Over The Counter Theme Music:

Warm Vacuum Tube by Admiral Bob (c)

Copyright 2019 Licensed under a Creative Commons Attribution (3.0) license

More from Europe

Over The Counter: What To Expect From The 61st AESGP Annual Meeting, With Jurate Švarcaite

 
• By 

HBW Insight speaks to AESGP director general Jurate Švarcaite about what's on the agenda for the upcoming 61st AESGP Annual Meeting, which will take place in Warsaw, Poland, between 2-4 June. Highlights include the role of prevention in self-care, discussions about how regulators will ensure the competitiveness of European industry on the world stage and incoming changes to sustainability legislation.

‘Nothing Unexpected’ In Third Failed Application For OTC Sildenafil In Germany

 
• By 

“Overall, no unexpected/new data or findings” were presented to Germany's Expert Committee for Prescription in the most recent Rx-to-OTC switch application for sildenafil (25mg and 50mg), according to medicines regulator BfArM, resulting in a third rejection in three years.

AESGP Slams ‘Deeply Concerning And Discriminatory’ EU Wastewater Directive

 
• By 

“Protecting the environment is a shared responsibility. It is unfair to expect only two sectors to fund wastewater treatment modernization and operation,” argues AESGP director general Jurate Švarcaite.

New Product Launches Ensured Growth For Stada CHC In 2024

 
• By 

Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.

More from Geography

New Product Launches Ensured Growth For Stada CHC In 2024

 
• By 

Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.

Maxwellia Launches UK TV Campaign For Evana Showing Reality Of Menstruation

 
• By 

Maxwellia's “bold, honest, and completely unfiltered” campaign for Evana menstrual health brand tells the story of a woman dealing with the realities of a heavy period, showing “real blood, real leaks.”

Over The Counter: Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell

 
• By 

HBW Insight catches up with Maxwellia CEO Anna Maxwell to discuss her company's journey so far, and what she sees as the opportunities for Rx-to-OTC switch in UK women's health and beyond.